Emmanuel Gougé's guest appearances

Emmanuel Gougé

Brand & New

Keith Ferrazzi

Duncan Wardle

Rebecca Tushnet

Scott Phillips

Frank Stanton

Tim Moss

Shep Hyken

Julie Zerbo

Arent Fox

David Bernstein

Perkins Coie

Megan Noh

Andrew Grotto

Jeff Fromm

Margaret McKeown

OwlTail

Marc Holtorf

News reports have never been as science-oriented as they tend to be these days due to the COVID-19 pandemic. Testing capacities, hospital medical equipment, potential treatments, and vaccine research are front and center, and it seems it is going to stay that way for some time given the direct and tangible stake that the public has in all those discussions. And as a consequence, pharmaceuticals and life sciences stakeholders—major intellectual property (IP) rights holders—are suddenly expected to deliver solutions to solve a major, worldwide health crisis. Our guests today, Marc Holtorf and Emmanuel Gougé are partners at the law firm Pinsent Masons in Munich, Germany, and Paris, France, respectively.  They both specialize in IP law, advising international companies on their IP management, development, and enforcement strategies. Mr. Holtorf has been working for the life sciences practice of international law firms for over 20 years, and he is now the Head of IP and Life Sciences for Germany at Pinsent Masons. Mr. Gougé also has over 20 years of experience as an IP attorney, with experience in the UK, Belgium and France, where he leads the Intellectual Property department. They share with us their perspective on the very unique situation the life sciences sector finds itself into these days, in between the private market dynamics and the imperatives of global health policies and the public interest.Every two weeks, on Tuesday, Brand &amp; New gives the floor to inspiring individuals, with a 360-degree vision, to help brand owners, intellectual property lawyers, and marketing and finance professionals (and beyond!) stay curious and agile in an ever-evolving business environment. Brand &amp; New is a production of the International Trademark AssociationHosted by Audrey Dauvet Contribution of M. Halle &amp; S. Lagedamond - Music by JD BeatsFOR MORE INFORMATION, VISIT INTA.ORGTo go further:About Emmanuel Gougé (link to https://www.linkedin.com/in/emmanuel-gougé-043a974b/) About Marc Holtorf (link to https://www.linkedin.com/in/marc-l-holtorf-500aa9b7/)Also of interest:-       MIT COVID-19 Open Research Dataset (link to https://innovation.mit.edu/cord19/)-       Pinsent Masons Analysis about COVID-19 Patents Rights and Public Interest (link to https://www.pinsentmasons.com/out-law/analysis/coronavirus-patents-rights-public-interest)-       Forbes, Innovation Imperatives from COVID-19 (link to https://www.forbes.com/sites/henrychesbrough/2020/03/18/innovation-imperatives-from-covid-19/#6dbf48456fb1)

News reports have never been as science-oriented as they tend to be these days due to the COVID-19 pandemic. Testing capacities, hospital medical equipment, potential treatments, and vaccine research are front and center, and it seems it is going to stay that way for some time given the direct and tangible stake that the public has in all those discussions. And as a consequence, pharmaceuticals and life sciences stakeholders—major intellectual property (IP) rights holders—are suddenly expected to deliver solutions to solve a major, worldwide health crisis. Our guests today, Marc Holtorf and Emmanuel Gougé are partners at the law firm Pinsent Masons in Munich, Germany, and Paris, France, respectively.  They both specialize in IP law, advising international companies on their IP management, development, and enforcement strategies. Mr. Holtorf has been working for the life sciences practice of international law firms for over 20 years, and he is now the Head of IP and Life Sciences for Germany at Pinsent Masons. Mr. Gougé also has over 20 years of experience as an IP attorney, with experience in the UK, Belgium and France, where he leads the Intellectual Property department. They share with us their perspective on the very unique situation the life sciences sector finds itself into these days, in between the private market dynamics and the imperatives of global health policies and the public interest.Every two weeks, on Tuesday, Brand &amp; New gives the floor to inspiring individuals, with a 360-degree vision, to help brand owners, intellectual property lawyers, and marketing and finance professionals (and beyond!) stay curious and agile in an ever-evolving business environment. Brand &amp; New is a production of the International Trademark Association Hosted by Audrey Dauvet Contribution of M. Halle &amp; S. Lagedamond - Music by JD Beats FOR MORE INFORMATION, VISIT <a href="http://inta.org/" rel="nofollow" target="_blank">INTA.ORG</a>To go further: About Emmanuel Gougé (link to <a href="https://www.linkedin.com/in/emmanuel-gougé-043a974b/" rel="nofollow" target="_blank">https://www.linkedin.com/in/emmanuel-gougé-043a974b/</a>) About Marc Holtorf (link to <a href="https://www.linkedin.com/in/marc-l-holtorf-500aa9b7/" rel="nofollow" target="_blank">https://www.linkedin.com/in/marc-l-holtorf-500aa9b7/</a>) Also of interest: -       MIT COVID-19 Open Research Dataset (link to <a href="https://innovation.mit.edu/cord19/" rel="nofollow" target="_blank">https://innovation.mit.edu/cord19/</a>) -       Pinsent Masons Analysis about COVID-19 Patents Rights and Public Interest (link to <a href="https://www.pinsentmasons.com/out-law/analysis/coronavirus-patents-rights-public-interest" rel="nofollow" target="_blank">https://www.pinsentmasons.com/out-law/analysis/coronavirus-patents-rights-public-interest</a>) -       Forbes, Innovation Imperatives from COVID-19 (link to <a href="https://www.forbes.com/sites/henrychesbrough/2020/03/18/innovation-imperatives-from-covid-19/#6dbf48456fb1" rel="nofollow" target="_blank">https://www.forbes.com/sites/henrychesbrough/2020/03/18/innovation-imperatives-from-covid-19/#6dbf48456fb1</a>)

The Life Sciences Sector in Times of Pandemic: Innovation and Public Interest (with Marc Holtorf, Partner and Emmanuel Gougé, Partner, Pinsent Masons)